NEW YORK, Sept. 8, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0611077/Global-Glucosamine-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Vitamin_a
This report analyzes the worldwide markets for Glucosamine in Metric Tons. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 148 companies including many key and niche players such as Alcan Chemical Division, Alfa Chem, Cargill, Inc., CMP Therapeutics Ltd., Dalian Lijian Bio-Technology Development Co., Ltd., Dalian Xindie Chitin Co., Ltd., Dee Pharmaceuticals Ltd., Ethical Naturals, Inc., FabriChem, Inc., Golden-Shell Biochemical Co., Ltd., Koyo Chemical Company Limited, Navamedic ASA, Nutraceutix, Inc., Nutramax Laboratories, Inc., NUTRILITE, Promax Nutrition Corporation, Schiff Nutrition International, Inc., Shandong DongYing Development Zone Marine Biochemical Co., Ltd., Shandong Jinan Haidebei Marine BioengineeringCo. Ltd., Simply Supplements, Synasia, Inc., Taizhou Candorly Sea Biochemical & Health Products Co., Ltd., Triarco Industries, Inc., Xiamen Blue Bay Science & Technology Co., Ltd., and Zhejiang Freeman Shinfuda Co. Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
2. MARKET OVERVIEW 4
Glucosamine: The Leading Dietary Supplement in the Joint
Health Market 4
Global Market Analysis 4
Market Trends 6
Nutritional Supplements Industry Remains Resilient to
Economic Downturn 6
Aging Population Drives Glucosamine Market 6
Table 1: Worldwide Distribution of 65+ Population by
Region/Country: As on July 2009 (includes corresponding
Graph/Chart) 6
China Races Ahead in Glucosamine Production and Supply Worldwide 7
Newer Formulations of Glucosamine Being Introduced 7
Glucosamine Fortification: An Emerging Trend 8
Table 2: Glucosamine Product Launches by Region (2006-2009):
Asia-Pacific, North America, and Europe (includes
corresponding Graph/Chart) 8
Plant-Derived Glucosamine Gains Popularity 9
Combination Supplements: A Double Whammy Success 9
Select Combination Supplements At a Glance 10
Functional Food and Beverages: Promising End-Market for
Glucosamine 10
Alternative Joint Health Ingredients May Have an Impact on
Future Sales 10
3. PRODUCT OVERVIEW 12
Glucosamine and the Benefits Offered 12
Why Glucosamine Supplements? 12
Chitin and Chitosan: A Prelude 12
Manufacturing of Glucosamine 13
Forms of Glucosamine 13
Glucosamine Sulfate Takes the Front Seat 13
Glucosamine Hydrochloride: Efficacy Still Doubted 14
Glucosamine and Recommended Dose 14
Glucosamine Interactions 14
Combo Power: Glucosamine Plus Other Ingredients 14
Diverse Views on Glucosamine/Chondroitin Use for
Osteoarthritis Treatment 14
CosaminDS Ranked No.1 15
Shifting Preferences Towards Glucosamine Plus MSM Supplement 15
Glucosamine and Omega-3 Fatty Acids: A New Combination 16
Select Glucosamine Supplements Available in the Market - A Review 16
Oral Glucosamine 16
Osteo Bi-Flex® (NBTY, Inc.) 16
Move Free® Advanced (Schiff Nutrition Group, Inc.) 16
Cosamin® DS (Nutramax Laboratories, Inc) 17
TripleFlex® (Pharmavite LLC) 17
Vegetarian Glucosamine 17
Regenasure® (Cargill) 17
Regenasure Applications by Select Country 18
JointAstin (Cyanotech) 18
Liquid Vegetarian Glucosamine/MSM (Trace Minerals Research) 18
Avoca® ASU (Nutramax Laboratories, Inc.) 18
GlucosaGreen (Hygieia Health) 18
GreenGrown glucosamine (Ethical Naturals, Inc.) 19
Liquid Glucosamine 19
Major Liquid Glucosamine Brands 19
Topical Glucosamine Still Inferior Over Other Formulations 19
Urah™ TGC: A Topical Glucosamine Brand 20
4. NEW RESEARCH FINDINGS ON GLUCOSAMINE 21
High Doses of Glucosamine Supplements Can Increase Diabetes Risk 21
Zero Adverse Affects of Oral Glucosamine on Glucose Metabolism 21
Glucosamine Fails to Relieve Lower Back Pain 21
Positive Affects of Glucosamine Sulfate and Omega-3 Combo on
Joint Health 21
Eggshell Membrane Outweighs Glucosamine for Joint Health Under
ESM Funded Clinical Trial 22
Prolonged Use of High Purity and Concentrated Chondroitin
Sulphate May Avoid Joint Degradation 22
InterHealth's Patented Collagen Ingredient Outperforms
Glucosamine and Chondroitin for Joint Health 22
Glucosamine to Treat UV- Related Skin Damage 23
Glucosamine Feared to Affect Fertility 23
5. PRODUCT INTRODUCTIONS AND LAUNCHES 24
Simply Supplements Launches Glucosamine Supplements for Bone
Health 24
OXIS Launches ErgoFlex™ Dietary Supplements 24
MonaVie Introduces MonaVie Active and MonaVie Original 24
Forum Health to Launch Glucosamine Hydrochloride Supplement 24
Nutramax Launches Start Cosamin® ASU Program 24
Schiff Nutrition Rolls Out Move Free® Advanced, the Next-
generation Joint Care Product 25
Nutrilite Unveils Glucosamine-7 for Better Joint Comfort in
Shorter Period 25
Promax Nutrition Launches Joint Xpress™ 26
Cargill and The Elations Company to Introduce the Elations®
Joint Health Supplement Beverages 26
Triarco Launches Liquid Glucosamine 26
Ethical Naturals Rolls Out GreenGrown Glucosamine 27
Planet Nutrition Introduces Planet Nutrition Supplements Range 27
Pharma Base Introduces Osamine™ Pharmaceutical Grade Glucosamine 27
Dr Organics Unveils Body Shot 27
Navamedic Launches Mobilat Glucosamin 27
Health Perception Launches GlucOsamax Extra 28
Herbalife Unveils a Series of Anti-Aging Products Containing
Glucosamine 28
Schiff Nutrition Launches New Move Free® Advanced 28
Reno Introduces New Liquid Dietary Supplement 28
Health Perception Launches ArheumaCare 28
Neptune Technologies Introduces Glucosamine/NKO™ 29
BR Pharmaceuticals Reintroduces Valupak 29
6. RECENT INDUSTRY ACTIVITY 30
Corwin Beverage to Distribute TandemRain's Sports Rejuvenation
Products 30
Dee Pharma Signs Exclusive Permanent Distribution Deal with
Laboratoires Expanscience 30
Thai Union and Nippon Suisan Joint Venture to Manufacture
Glucosamine 30
Camlin Fine Chemicals to Foray into the US and European Markets 30
Ethical Naturals and Cargill Reconciles Glucosamine Patent
Dispute 30
Koyo Chemical to Expand Product Portfolio 31
Bayer HealthCare Acquires OTC Business of Sagmel 31
Hygieia Receives EU Approval for GlucosaGreen, a Vegetarian
Glucosamine 31
Navamedic Inks Agreement with Queisser Pharma 32
Lescarden Receives First Poly-NAG Order from Pascual Laboratories 32
Navamedic Divests ChitiNor to Seagarden 32
Navamedic Enters into a Deal with William Ransom 32
Navamedic Signs Agreement with French Partner to Market Glucomed 33
7. FOCUS ON SELECT PLAYERS 34
Alcan Chemical Division (US) 34
Alfa Chem (US) 34
Cargill, Inc. (US) 34
CMP Therapeutics Ltd. (UK) 35
Dalian Lijian Bio-Technology Development Co., Ltd (China) 35
Dalian Xindie Chitin Co., Ltd. (China) 35
Dee Pharmaceuticals Ltd (UK) 35
Ethical Naturals, Inc. (US) 36
FabriChem, Inc. (US) 36
Golden-Shell Biochemical Co., Ltd. (China) 36
Koyo Chemical Company Limited (Japan) 36
Navamedic ASA (Norway) 37
Nutraceutix, Inc. (US) 37
Nutramax Laboratories, Inc. (US) 37
NUTRILITE (US) 37
Promax Nutrition Corporation (US) 38
Schiff Nutrition International, Inc. (US) 38
Shandong DongYing Development Zone Marine Biochemical Co.,
Ltd. (China) 39
Shandong Jinan Haidebei Marine Bioengineering Co. Ltd. (China) 39
Simply Supplements (UK) 39
Synasia, Inc. (US) 40
Taizhou Candorly Sea Biochemical & Health Products Co., Ltd.
(China) 40
Triarco Industries, Inc (USA) 40
Xiamen Blue Bay Science & Technology Co., Ltd (China) 41
Zhejiang Freeman Shinfuda Co. Ltd. (China) 41
8. GLOBAL MARKET PERSPECTIVE 42
Table 3: World Recent Past, Current & Future Analysis for
Glucosamine by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in Metric
Tons for Years 2009 through 2017 (includes corresponding
Graph/Chart) 42
Table 4: World Historic Review for Glucosamine by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales Figures in Metric Tons for Years 2003 through
2008 (includes corresponding Graph/Chart) 43
Table 5: World 15-Year Perspective for Glucosamine by
Geographic Region - Percentage Breakdown of Volume Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2003, 2010 & 2017 (includes
corresponding Graph/Chart) 44
9. THE UNITED STATES 45
A.Market Analysis 45
Current and Future Analysis 45
Arthritis: A Major Cause of Disability Among Elderly 45
Glucosamine: A Good Fit for Joint Problems 45
Market Overview 46
Key Trends & Issues 46
Private Label Emerges as a Popular Choice Amid Recession 46
Glucosamine Containing Products Grow in Number 46
Product Introductions 47
Strategic Corporate Developments 50
Focus on Select Players 51
B.Market Analytics 56
Table 6: The US Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 56
Table 7: The US Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 56
10. CANADA 57
Market Analysis 57
Table 8: Canadian Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 57
Table 9: Canadian Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 57
11. JAPAN 58
A.Market Analysis 58
Strategic Corporate Development 58
Koyo Chemical Company Limited - A Key Player 58
B.Market Analytics 59
Table 10: Japanese Recent Past, Current & Future Analysis
for Glucosamine - Annual Sales Figures in Metric Tons for
Years 2009 through 2017 (includes corresponding Graph/Chart) 59
Table 11: Japanese Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 59
12. EUROPE 60
A.Market Analysis 60
The United Kingdom: A High Growth Market for Vitamins,
Minerals and Supplements 60
Table 12: UK Market for Vitamins, Minerals, and Supplements
(2007): Percentage Market Share Breakdown for
Multivitamins, Fish Oils, Single Vitamins, Glucosamine,
Evening Primrose & starflower Oils, Minerals, and Others
(includes corresponding Graph/Chart) 60
Table 13: UK Life Expectancy by Gender (1950-2020)
(includes corresponding Graph/Chart) 61
Product Introductions 61
Strategic Corporate Developments 62
Focus on Select Players 63
B.Market Analytics 65
Table 14: European Recent Past, Current & Future Analysis
for Glucosamine by Geographic Region - France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in Metric
Tons for Years 2009 through 2017 (includes corresponding
Graph/Chart) 65
Table 15: European Historic Review for Glucosamine by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in Metric Tons for Years 2003
through 2008 (includes corresponding Graph/Chart) 66
Table 16: European 15-Year Perspective for Glucosamine by
Geographic Region - Percentage Share Breakdown of Volume
Sales for France, Germany, Italy, UK, Spain, Russia, and
Rest of Europe Markets for Years 2003, 2010 and 2017
(includes corresponding Graph/Chart) 67
12a. FRANCE 68
Market Analysis 68
Table 17: French Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 68
Table 18: French Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 68
12b. GERMANY 69
Market Analysis 69
Table 19: German Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 69
Table 20: German Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 69
12c. ITALY 70
Market Analysis 70
Table 21: Italian Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 70
Table 22: Italian Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 70
12d. THE UNITED KINGDOM 71
Market Analysis 71
Table 23: The UK Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 71
Table 24: The UK Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 71
12e. SPAIN 72
Market Analysis 72
Table 25: Spanish Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 72
Table 26: Spanish Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 72
12f. RUSSIA 73
Market Analysis 73
Table 27: Russian Recent Past, Current & Future Analysis for
Glucosamine - Annual Sales Figures in Metric Tons for Years
2009 through 2017 (includes corresponding Graph/Chart) 73
Table 28: Russian Historic Review for Glucosamine - Annual
Sales Figures in Metric Tons for Years 2003 through 2008
(includes corresponding Graph/Chart) 73
12g. REST OF EUROPE 74
Market Analysis 74
Table 29: Rest of Europe Recent Past, Current & Future
Analysis for Glucosamine - Annual Sales Figures in Metric
Tons for Years 2009 through 2017 (includes corresponding
Graph/Chart) 74
Table 30: Rest of Europe Historic Review for Glucosamine -
Annual Sales Figures in Metric Tons for Years 2003 through
2008 (includes corresponding Graph/Chart) 74
13. ASIA-PACIFIC 75
A.Market Analysis 75
China - Poised to Become Major Glucosamine Consumer 75
Arthritis in Australia 75
Product Introductions 75
Focus on Select Players 76
B.Market Analytics 79
Table 31: Asia-Pacific Recent Past, Current & Future
Analysis for Glucosamine - Annual Sales Figures in Metric
Tons for Years 2009 through 2017 (includes corresponding
Graph/Chart) 79
Table 32: Asia-Pacific Historic Review for Glucosamine -
Annual Sales Figures in Metric Tons for Years 2003 through
2008 (includes corresponding Graph/Chart) 80
14. REST OF WORLD 81
Market Analysis 81
Table 33: Rest of the World Recent Past, Current & Future
Analysis for Glucosamine - Annual Sales Figures in Metric
Tons for Years 2009 through 2017 (includes corresponding
Graph/Chart) 81
Table 34: Rest of the World Historic Review for Glucosamine-
Annual Sales Figures in Metric Tons for Years 2003 through
2008 (includes corresponding Graph/Chart) 82
COMPETITIVE LANDSCAPE
Total Companies Profiled: 148 (including Divisions/Subsidiaries - 150)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 60
Canada 5
Japan 5
Europe 21
Germany 2
The United Kingdom 11
Italy 1
Spain 2
Rest of Europe 5
Asia-Pacific (Excluding Japan) 58
Africa 1
------------------------------------------
To order this report:
Vitamin and Supplement Industry: Global Glucosamine Industry
Vitamin and Supplement Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article